SterRx, LLC: Drug Recall
Recall #D-0322-2022 · 11/12/2021
Class II: Risk
Recall Details
- Recall Number
- D-0322-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- SterRx, LLC
- Status
- Terminated
- Date Initiated
- 11/12/2021
- Location
- Plattsburgh, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 36,576 bags
Reason for Recall
Lack of Assurance of Sterility
Product Description
NOREPINEPHRINE, 16 mg per 250 mL, (64 mcg per mL) in 0.9% Sodium Chloride Injection, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-926-01.
Distribution Pattern
U.S.A. Nationwide
Other Recalls by SterRx, LLC
- Class II: Risk 07/07/2023
- Class II: Risk 07/07/2023
- Class II: Risk 07/07/2023
- Class II: Risk 07/07/2023
- Class II: Risk 07/07/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.